Long non-coding RNA HoxA-AS3 interacts with EZH2 to regulate lineage commitment of mesenchymal stem cells

Xin-Xing Zhu; Ya-Wei Yan; Demeng Chen; Chun-Zhi Ai; Xifeng Lu; Shan-Shan Xu; Shan Jiang; Gen-Shen Zhong; Dong-Bao Chen; Yi-Zhou Jiang

doi:10.18632/oncotarget.11538

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

This article has been corrected. Correction in: Oncotarget. 2018; 9:17978.

Long non-coding RNA HoxA-AS3 interacts with EZH2 to regulate lineage commitment of mesenchymal stem cells

Xin-Xing Zhu, Ya-Wei Yan, Demeng Chen, Chun-Zhi Ai, Xifeng Lu, Shan-Shan Xu, Shan Jiang, Gen-Shen Zhong, Dong-Bao Chen and Yi-Zhou Jiang _

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2016; 7:63561-63570. https://doi.org/10.18632/oncotarget.11538

Metrics: PDF 3226 views | HTML 3950 views | ?

Abstract

Xin-Xing Zhu1,*, Ya-Wei Yan1,*, Demeng Chen2, Chun-Zhi Ai1, Xifeng Lu3, Shan-Shan Xu1, Shan Jiang1, Gen-Shen Zhong4, Dong-Bao Chen5, Yi-Zhou Jiang1

1Institute for Advanced Study, Shenzhen University, Shenzhen, Guangdong, China

2School of Dentistry, University of California, Los Angeles, CA, USA

3Department of Physiology, Center for Diabetes, Obesity and Metabolism, Shenzhen University Health Science Center, Shenzhen University, Shenzhen, Guangdong, China

4Henan Key Laboratory of Neural Regeneration and Repairment, The First affiliated Hospital of Xinxiang Medical University, Weihui, Henan, China

5Department of Obstetrics and Gynecology, University of California, Irvine, CA, USA

*These authors contributed equally to this work

Correspondence to:

Yi-Zhou Jiang, email: [email protected]

Keywords: mesenchymal stem cells, HoxA-AS3, lineage specification, enhancer of zeste homolog 2, long non-coding RNA

Received: June 16, 2016 Accepted: August 15, 2016 Published: August 23, 2016

ABSTRACT

Long non-coding RNAs (lncRNAs) play an important role in gene regulation and are involving in diverse cellular processes. However, their roles in reprogramming of gene expression profiles during lineage commitment and maturation of mesenchymal stem cells (MSCs) remain poorly understood. In the current study, we characterize the expression of a lncRNA, HoxA-AS3, during the differentiation of MSCs. We showed that HoxA-AS3 is increased upon adipogenic induction of MSCs, while HoxA-AS3 remains unaltered during osteogenic induction. Silencing of HoxA-AS3 in MSCs resulted in decreased adipogenesis and expression of adipogenic markers, PPARG, CEBPA, FABP4 and ADIPOQ. Conversely, knockdown of HoxA-AS3 expression in MSCs exhibited an enhanced osteogenesis and osteogenic markers expression, including RUNX2, SP7, COL1A1, IBSP, BGLAP and SPP1. Mechanistically, HoxA-AS3 interacts with Enhancer Of Zeste 2 (EZH2) and is required for H3 lysine-27 trimethylation (H3K27me3) of key osteogenic transcription factor Runx2. Our data reveal that HoxA-AS3 acts as an epigenetic switch that determines the lineage specification of MSC.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 11538

Publication Alerts

Research Papers:

Long non-coding RNA HoxA-AS3 interacts with EZH2 to regulate lineage commitment of mesenchymal stem cells

Abstract